bd-capital invests in Symprove Ltd.

On July 9, 2020, bd-capital invested in Symprove Ltd., a life science company in United Kingdom.

Deal at a glance

AnnouncedJuly 9, 2020 TypeGrowth Capital TargetSymprove Ltd. Buyer bd-capital SectorLife Science LocationUnited Kingdom ValueNot disclosed

Target company

Symprove Ltd.

United Kingdom

Life Sciencesector

2008founded

Activestatus

View the company profile →

Buyer

bd-capital

Company · 1 deal on record

1st transaction in life science
1st transaction in United Kingdom

1deals, all time

1in this sector

2020latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Drug Development SolutionsSame sector and country · May 2022

Aptus Clinical Ltd.Same sector and country · May 2022

Panthera BiopartnersSame sector and country · Apr 2022

Questions about this deal

Who acquired Symprove Ltd.?bd-capital invested in Symprove Ltd. on July 9, 2020.

What type of deal was it?It was a growth capital in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).